The recommendations follow an evidence review by the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization2 in October 2017.
As a result of the WHO prequalification achieved in December of 2017, developing countries can apply for funding from Gavi, the Global Alliance for Vaccines & Immunization, which approved $85 million in funding for 2019-20 for the new typhoid vaccine’s introduction.3 The vaccine is expected to be fully released in mid-2019.
The Bill & Melinda Gates Foundation-funded Typhoid Vaccine Acceleration Consortium (TyVAC) clinical trial6 focused on the vaccine’s cost effectiveness and efficacy began in February in Malawi. It includes 24,000 children aged nine months to 12 years. The study is in partnership with the University of Maryland School of Medicine’s Center for Vaccine Development, the University of Oxford’s Oxford Vaccine Group and international nonprofit PATH.
1 Sabin Vaccine Institute. WHO recommends use of first typhoid conjugate vaccine. Sabin Vaccine Institute (press release) Apr. 3, 2018.
2 World Health Organization. Weekly epidemiological record. World Health Organization No 48, 2017, 92, 729–748 Dec. 1, 2017.
3 Gavi, The Vaccine Alliance. Millions of children set to be protected against typhoid fever. Gavi, The Vaccine Alliance (press release) Nov. 30, 2017.
4 First Typhoid Conjugate Vaccine Recommended by WHO. Contagion Apr. 3, 2018.
5 WHO. Typhoid Fact Sheet. WHO.int January 2018.
2 Responses to "WHO Recommends New Typhoid Vaccine"
This isn’t much of an article…..dry reporting. Provokes many questions that the author is unaware of?